| Wall Street Journal. Europe 2007 jeanne Whalen |
| Title | Subject | Authors |
|---|
| An unusual race to become Glaxo's next CEO.(GlaxoSmithKline PLC) | Business, international | Joann S. Lublin, Jeanne Whalen |
| AstraZeneca, Bristol-Myers to team up on two drugs.(Type 2 diabetes)(pharmaceuticals)(includes Stock Quotes statistical table)(Industry overview)(Financial report) | Business, international | Jeanne Whalen |
| AstraZeneca hopes purchase breaks new-product slump: MedImmune offers access to vaccines, biological drugs.(JEANNE WHALEN and ANITA GREIL) | Business, international | Jeanne Whalen, Anita Greil |
| Bayer is asked to suspend Trasylol sales. | Business, international | Jeanne Whalen, Anna Wilde Mathews |
| Drug makers try to bring back Cox-2 inhibitors.(Merck & Company Inc., Novartis AG, Pfizer Inc.) | Business, international | Jeanne Whalen |
| Europe drug firms join slimming trend: Akzo and Merck KGaA look to unload units to focus on core assets.(Akzo Nobel N.V.) | Business, international | Jeanne Whalen, Mike Esterl, Tjeerd Wiersma |
| Europe's drug insurers try pay-for-performance. | Business, international | Jeanne Whalen |
| Glaxo plans to trim jobs as profit falls.(GlaxoSmithKline PLC)(Financial report) | Business, international | Jeanne Whalen |
| Merck KGaA draws bidders for generics.(pharmaceuticals)(Germany)(includes Stock Quotes statistical table)(Financial report) | Business, international | Jeanne Whalen, Peter Wonacutt |
| 'Miracle' obesity pill looks less miraculous: repeated FDA delays, European restrictions ail Sanofi's Acomplia.(Page One) | Business, international | Jeanne Whalen |
| Nestle bolsters baby-food line: purchase from Novartis ends chase begun in 1994, fills hole in U.S. portfolio. | Business, international | Jeanne Whalen |
| Novartis angers critics in India: challenge of patent laws creates uproar among public-health advocates. | Business, international | Peter Wonacott, Jeanne Whalen |
| Novartis case furthers India patent debate. | Business, international | Jeanne Whalen |
| Novartis drug approved by EU.(European Union) | Business, international | Jeanne Whalen, Anna Wilde Mathews |
| Novartis has potential blockbuster as FDA backs blood-pressure drug.(Tekturna) | Business, international | Jeanne Whalen, Anita Greil |
| Novartis plans restructuring: CEO Vasella says moves aim to trim bureaucracy layers.(Chief Executive Officer Daniel Vasella) | Business, international | Jeanne Whalen |
| Novartis shakes ranks as earnings flag: management swap, job cuts aim to cope with shifts in market.(Financial report) | Business, international | Jeanne Whalen, Goran Mijuk |
| Novartis to focus on influence insurers wield over doctors. | Business, international | Jeanne Whalen |
| Outbreak's toll hits U.K. beef industry.(foot-and-mouth disease) | Business, international | Jeanne Whalen, Deborah Ball |
| Roche's pick for next CEO marks a bet on diagnostics: Schwan to push technology that spots, tracks disease; first-half net grew 24%.(Chief Executive Officer Severin Schwan, Roche Holding AG)(Financial report) | Business, international | Jeanne Whalen |
| Sanofi CEO promises clearer picture.(Sanofi-Aventis S.A.)(Chief Executive Officer Gerard Le Fur)(includes Stock Quotes statistical table)(Company overview)(Financial report) | Business, international | Jeanne Whalen |
| Sanofi's bird-flu vaccine is granted FDA approval: first human treatment is seen as stopgap aid as research continues. | Business, international | Jeanne Whalen, Anna Wilde Mathews, Laura Meckler |
| Sanofi withdraws obesity-drug application in U.S. | Business, international | Jeanne Whalen |
| Schering-Plough tries to deal its way to top.(Organon BioSciences N.V. acquisition) | Business, international | Jeanne Whalen, Sarah Rubenstein |
| Shareholders sue Glaxo over Avandia disclosure.(GlaxoSmithKline PLC) | Business, international | Jeanne Whalen |
| Small firms seek to profit from drug giants' castoffs. | Business, international | Jeanne Whalen |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
